Burgess Caroline, Cornelius Victoria, Love Sharon, Graham Jill, Richards Michael, Ramirez Amanda
Cancer Research UK London Psychosocial Group, Institute of Psychiatry, King's College London, St Thomas's Hospital, London SE1 7EH.
BMJ. 2005 Mar 26;330(7493):702. doi: 10.1136/bmj.38343.670868.D3. Epub 2005 Feb 4.
To examine the prevalence of, and risk factors for, depression and anxiety in women with early breast cancer in the five years after diagnosis.
Observational cohort study.
NHS breast clinic, London.
222 women with early breast cancer: 170 (77%) provided complete interview data up to either five years after diagnosis or recurrence.
Prevalence of clinically important depression and anxiety (structured psychiatric interview with standardised diagnostic criteria) and clinical and patient risk factors, including stressful life experiences (Bedford College life events and difficulties schedule).
Nearly 50% of the women with early breast cancer had depression, anxiety, or both in the year after diagnosis, 25% in the second, third, and fourth years, and 15% in the fifth year. Point prevalence was 33% at diagnosis, falling to 15% after one year. 45% of those with recurrence experienced depression, anxiety, or both within three months of the diagnosis. Previous psychological treatment predicted depression, anxiety, or both in the period around diagnosis (one month before diagnosis to four months after diagnosis). Longer term depression and anxiety, were associated with previous psychological treatment, lack of an intimate confiding relationship, younger age, and severely stressful non-cancer life experiences. Clinical factors were not associated with depression and anxiety, at any time. Lack of intimate confiding support also predicted more protracted episodes of depression and anxiety.
Increased levels of depression, anxiety, or both in the first year after a diagnosis of early breast cancer highlight the need for dedicated service provision during this time. Psychological interventions for women with breast cancer who remain disease free should take account of the broader social context in which the cancer occurs, with a focus on improving social support.
调查早期乳腺癌女性患者在确诊后五年内抑郁症和焦虑症的患病率及危险因素。
观察性队列研究。
伦敦的国民保健服务乳腺诊所。
222例早期乳腺癌女性患者,其中170例(77%)在确诊后五年内或复发前提供了完整的访谈数据。
具有临床意义的抑郁症和焦虑症的患病率(采用标准化诊断标准的结构化精神科访谈)以及临床和患者危险因素,包括应激性生活经历(贝德福德学院生活事件与困难量表)。
近50%的早期乳腺癌女性患者在确诊后第一年出现抑郁症、焦虑症或两者皆有,第二、三、四年为25%,第五年为15%。确诊时的时点患病率为33%,一年后降至15%。45%的复发患者在确诊后三个月内出现抑郁症、焦虑症或两者皆有。既往接受过心理治疗预示着在确诊前后(确诊前一个月至确诊后四个月)会出现抑郁症、焦虑症或两者皆有。长期的抑郁症和焦虑症与既往心理治疗、缺乏亲密倾诉关系、年龄较小以及严重应激性非癌症生活经历有关。临床因素在任何时候都与抑郁症和焦虑症无关。缺乏亲密倾诉支持也预示着抑郁症和焦虑症发作会更持久。
早期乳腺癌确诊后第一年抑郁症、焦虑症或两者皆有水平的升高凸显了在此期间提供专门服务的必要性。对无疾病复发的乳腺癌女性进行心理干预时应考虑到癌症发生的更广泛社会背景,重点是改善社会支持。